Colonial River Investments’s GSK GSK Stock Holding History

Colonial River Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,618	Closed	-$222K	–	243
2025 Q2	$222K	Buy	5,618 +172	+3%	+$6.57K	0.1%	203
2025 Q1	$211K	Buy	+5,446	New	+$199K	0.12%	188
2024 Q4	–	Sell	-5,435	Closed	-$222K	–	219
2024 Q3	$222K	Sell	5,435 -318	-6%	-$13K	0.11%	196
2024 Q2	$221K	Sell	5,753 -80	-1%	-$3.37K	0.12%	149
2024 Q1	$250K	Buy	+5,833	New	+$241K	0.14%	140
2023 Q3	–	Sell	-16,461	Closed	-$587K	–	160
2023 Q2	$587K	Buy	+16,461	New	+$590K	0.39%	76

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Colonial River Investments's GSK Position: Q3 2025 in Review

Colonial River Investments sold out of GSK (GSK) in Q3 2025, closing a stake of 5,618 shares — an estimated $222K sold.

Colonial River Investments first reported a position in GSK in Q2 2023 and held it in 6 quarters. The position peaked at $587K in Q2 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Colonial River Investments reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Colonial River Investments sold 5,618 GSK shares in Q3 2025, an estimated $222K.
Colonial River Investments first reported a position in GSK in Q2 2023 and held it in 6 quarters.
Colonial River Investments's GSK position peaked at $587K in Q2 2023.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Colonial River Investments's 13F filing for Q3 2025, filed 13 Nov 2025.